Intuitive Surgical’s Preliminary Results Beat Expectations
Intuitive Surgical’s Preliminary Results Beat Expectations

Intuitive Surgical’s Preliminary Results Beat Expectations

Jan. 9, 2024, 8:19 p.m., readers: 12

Intuitive Surgical (NASDAQ:ISRG) revealed its preliminary results for the fourth quarter, which exceeded the expectations of analysts. The company announced a preliminary revenue of $1.93 billion, surpassing the anticipated consensus of $1.87 billion. In detail, the revenue from Instruments and Accessories aligned with the forecast at $1.14 billion. However, the revenue from systems notably outperformed predictions, coming in at $480 million against the projected $420.7 million. Additionally, Intuitive Surgical experienced a significant worldwide procedure growth of around 21%, higher than the expected 18.9%. The company also noted the impact of COVID-19 resurgences in China on their early 2023 procedure volumes. Despite initial challenges, there was a subsequent recovery in procedure volume as infection rates and hospitalizations began to decrease.


I ntuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Price: 388.00
Market cap: 136.7 billion USD
Eps: 5.04
P/e ratio: 76.98
Terminal Research: ISRG
All news about: ISRG

More news about ISRG

Intuitive Surgical Beats Q4 Expectations
Jan. 24, 2024, 12:36 p.m.

Intuitive Surgical (NASDAQ:ISRG), renowned for its robotic-assisted surgical technology, reported its fourth-quarter earnings, exceeding …